Texas Instruments reported first-quarter revenue of $3.66 billion, which beat the consensus estimate of $3.611 billion, according to Benzinga Pro. The company's top-line results were down 16% on a year-over-year basis and down 10% sequentially as revenue declined across all end markets.
Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data.
Over the past 24 hours, Pepe's (CRYPTO: PEPE) price rose 15.13% to $0.0000077. This continues its positive trend over the past week where it has experienced a 46.0% gain, moving from $0.0000053 to its current price.
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Over the past 24 hours, Hedera's (CRYPTO: HBAR) price has risen 35.41% to $0.12. This continues its positive trend over the past week where it has experienced a 55.0% gain, moving from $0.08 to its current price. As it stands right now, the coin's all-time high is $0.57.
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday’s session after the company reported worse-than-expected quarterly financial results.…